--> Trial for new drug-resistant TB treatment to begin | AboutMicro News
'https://svgshare.com/s/YY2' >

Trial for new drug-resistant TB treatment to begin

Trial for new drug-resistant TB treatment to begin Tuberculosis wait to see doctors in South Africa in 2009. A global health alliance unve...


Trial for new drug-resistant TB treatment to begin


Tuberculosis wait to see doctors in South Africa in 2009. A global health alliance unveiled plans Monday for the first clinical tests for a new treatment regimen for tuberculosis, including for patients with resistance to existing multidrug programs. (AFP Photo/Alexander Joe)

A global health alliance Monday unveiled plans for the first clinical tests of a new treatment regimen for tuberculosis, including for patients with resistance to existing multidrug programs.
The TB Alliance, which is funded by several governments and foundations, said the new drug combination offers promise in the fight against TB, which kills an estimated 1.4 million people each year, mostly in Africa.
Health experts said the new program could be particularly useful for an estimated 650,000 people around the world who suffer from multidrug-resistant TB (MDR-TB), a number expected to rise, and could shorten treatment times.
"There is new momentum and new hope in TB research, as shown by this and several other novel regimen trials that will soon be launched," said Mel Spigelman, president and chief executive of the TB Alliance.
"This novel TB drug regimen has the potential to unlock a new and more efficient approach to tackling TB.
"In essence, it's a step toward erasing the distinction between TB and MDR-TB -- and in the process, dramatically shortening, simplifying, and improving treatment," he added.
Currently, someone with TB must take a course of drugs daily for six months, while those with MDR-TB must take a daily injection for the first six months and a dozen or more pills each day for 18 months or more.
Many TB patients fail to complete treatment because they cannot tolerate the difficult side effects of the medications or cannot adhere to the long-term treatment, according to the TB Alliance.
This leads to drug resistant forms of the disease, or even extensively drug-resistant TB known as XDR-TB.
"The current TB treatment takes too long, and all around the world, patients needlessly suffer because today's treatment is completely inadequate," said Francis George Apina of the Network of Men Living with HIV/AIDS in Kenya.
The TB Alliance receives funding from the Bill & Melinda Gates Foundation, Irish Aid, Britain's Department for International Development, the US Agency for International Development, and the US Food and Drug Administration.
The new regimen being tested could shorten required treatment to as little as four months in both patients with TB and some forms of drug-resistant TB, compared with the current six to 24 months. Costs will also be vastly reduced.
Once known as "consumption" for the slow wasting away of terminally-ill patients, one out of every three people is thought to be infected by the airborne TB organism, though only a fraction go on to develop the disease.
A total of 8.8 million people worldwide fell ill with the contagious lung disease in 2010 and around 1.4 million died, according to the World Health Organization (WHO).
The new trials will take place at eight sites in South Africa, Tanzania, and Brazil, the alliance said.
Dr Anthony Fauci, director of the US-based National Institute of Allergy and Infectious Diseases, said he was "optimistic" on the outlook for treating TB.
"We have put a lot of effort over the last few years in developing new drugs regimens and the clinical trial is a step in the right direction to trial and get new TB drugs, particularly for those against drugs resistance," he said.
"It's the first time we have tried to address the multi-resistance problem with a combination of new drugs. We tried before but not in combination," he added.

COMMENTS

Name

Agricultural,3,Auto,5,Consumer,46,Cooking,13,Crime,4,Critics Choice,1,Decore,4,Eco-Friendly,4,Education,30,Employment,5,Entertainment,193,Entrepreneurship,15,Fashion,71,Fashion Shows,111,Fashion Style,83,Finance,11,Food,31,Gardening,3,Gastronomy,10,Gourmet food,15,Health,101,History,13,illegal,9,Life Style,165,Luxury,22,Military,33,Movies,17,News,79,Novel,2,Pet,3,photography,11,Red Carpet,245,Royal,4,Scams,7,Science and Tech,116,Sports,27,Study,50,Super Model,22,Travel,117,Trends,24,World,130,Writers,5,
ltr
item
AboutMicro News: Trial for new drug-resistant TB treatment to begin
Trial for new drug-resistant TB treatment to begin
http://img.news.sina.com/life/p/2012/0319/U50P5029T2D450423F24DT20120320131500.jpg
AboutMicro News
https://aboutmicro-news.blogspot.com/2012/03/trial-for-new-drug-resistant-tb.html
https://aboutmicro-news.blogspot.com/
https://aboutmicro-news.blogspot.com/
https://aboutmicro-news.blogspot.com/2012/03/trial-for-new-drug-resistant-tb.html
true
1007093704318449624
UTF-8
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content